How should severe hypertension be managed before an elective surgery to achieve a target blood pressure below 140/90 mm Hg?

Management of Severe Hypertension Before Elective Surgery

For patients with severe hypertension (SBP ≥180 mm Hg or DBP ≥110 mm Hg) presenting for elective surgery, consider deferring surgery to optimize blood pressure control, particularly in patients with cardiovascular risk factors or undergoing elevated-risk procedures 1.

Risk Stratification and Decision Framework

The decision to proceed versus defer surgery depends on three critical factors:

1. Blood Pressure Threshold Assessment

• Stage 1-2 hypertension (BP <180/110 mm Hg): No clear evidence of increased perioperative cardiovascular risk in patients without target organ damage—proceed with surgery 2
• Stage 3 hypertension (BP ≥180/110 mm Hg): Associated with increased risk of myocardial ischemia, cardiovascular complications, and bleeding 1, 2
• Severe elevations (SBP ≥180 or DBP ≥110-120 mm Hg): The 2024 AHA/ACC guidelines recommend deferring elective elevated-risk surgery may be considered to reduce perioperative complications 1

2. Target Organ Damage Evaluation

Assess for evidence of hypertensive end-organ damage, which significantly increases perioperative risk 2:

• Cardiac: Left ventricular hypertrophy, heart failure, coronary artery disease
• Renal: Creatinine >2.0 mg/dL
• Cerebrovascular: Prior stroke or TIA
• Vascular: Peripheral arterial disease

Patients with stage 3 hypertension AND target organ damage have the highest risk and warrant deferral for optimization 2, 3.

3. Surgical Risk Assessment

• Elevated-risk surgery (vascular, major intra-abdominal, prolonged procedures): Higher threshold for deferral 1
• Low-risk surgery: May proceed with careful intraoperative monitoring even with poorly controlled hypertension 2

Medication Management Strategy

Continue Most Antihypertensives

It is reasonable to continue medical therapy for hypertension throughout the perioperative period in most patients 1. This includes:

• Beta-blockers (avoid abrupt discontinuation—risk of rebound hypertension) 1
• Calcium channel blockers
• Alpha-2 agonists like clonidine (avoid abrupt discontinuation) 1

Exercise Caution With Specific Drug Classes

• ACE inhibitors and ARBs: Associated with increased risk of intraoperative hypotension when continued 1
• Diuretics: Consider holding in patients at risk for volume depletion
• Particular caution in older adults (≥65 years) and those with low-normal baseline BP 1

When to Defer Surgery

Defer elective surgery when:

1. SBP ≥180 mm Hg or DBP ≥110 mm Hg on the day of surgery 1
2. Patient has cardiovascular risk factors (CAD, heart failure, stroke history, renal dysfunction, diabetes) 1
3. Planned procedure is elevated-risk 1
4. Evidence of target organ damage is present 2

Optimization Timeline

The evidence does NOT support acute blood pressure reduction in the days immediately before surgery 2, 4. When deferral is chosen:

• Optimize antihypertensive regimen over weeks to months, not days 4
• Target BP <140/90 mm Hg for most patients
• Restart preoperative antihypertensives as soon as clinically reasonable postoperatively to avoid rebound hypertension 1

Critical Caveats

The evidence base is limited: No rigorous RCTs have definitively proven that deferring surgery to treat severe hypertension reduces perioperative complications 2. The Weksler study showed no difference in cardiovascular outcomes between immediate surgery with acute BP reduction versus deferral 2.

Avoid these pitfalls:

• Do not use short-acting or IV antihypertensives for acute preoperative BP reduction—associated with adverse outcomes 5
• Do not defer surgery for mild-moderate hypertension (BP <180/110 mm Hg) without other risk factors 2, 6
• Do not abruptly discontinue beta-blockers or clonidine 1

Intraoperative and Postoperative Targets

• Maintain intraoperative MAP ≥60-65 mm Hg or SBP ≥90 mm Hg to reduce risk of myocardial injury 1
• Treat postoperative hypotension aggressively (MAP <60-65 or SBP <90 mm Hg) to limit cardiovascular, cerebrovascular, and renal complications 1
• Higher BP targets may be appropriate for older adults and those with chronic hypertension 1